Novo Nordisk A/S ADR buy BiotechBee
Start price
07.09.22
/
70%
€104.00
Target price
31.12.25
€180.00
Performance (%)
41.35%
End price
05.05.23
€147.00
Summary
This prediction ended on 05.05.23 with a price of €147.00. The BUY prediction by BiotechBee for Novo Nordisk A/S ADR saw massive gains of 41.35%. Dividends of €1.10 are taken into consideration when calculating the performance. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 0.000% | 0.000% | -17.895% |
| iShares Core DAX® | -3.935% | -3.998% | 11.192% |
| iShares Nasdaq 100 | -3.608% | -9.386% | 22.243% |
| iShares Nikkei 225® | -4.513% | -8.017% | 5.961% |
| iShares S&P 500 | -2.607% | -4.265% | 21.865% |
According to BiotechBee what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Buy mit Kursziel 180,0